Psychedelic drugs could be a major game-changer when it comes to treating mental illness, so loading up on some psychedelic stocks only makes sense. All as psilocybin, LSD, MDMA, and mescaline for example show progress in treating major issues such as obsessive-compulsive disorder, PTSD, addiction, depression and anxiety. New York University found that psilocybin lead…

Editor’s Note: This article is part of Joanna Makris’ Behind the Wall series, where she provides retail investors with the insider scoop on the hottest technologies and trends from today’s business leaders, industry experts and money managers. Today’s discussion is with Dustin Robinson, founder of venture capital firm Iter Investments, an early investor and policymaker in…

Putting it simply, penny stocks haven’t been so hot lately. Chalk this up to both the deflating of the meme stock bubble, as well as overall market volatility. Not only have popular names in this category (stocks priced at $5 or less) moved lower. Many once-hot names have tanked to the point where they too…

Even though some penny stocks have multi-bagger potential, they’re incredibly risky. The companies behind them typically haven’t had much experience in the marketplace. However, well-known companies may also fall under this category if their shares have plummeted. With proper due diligence and diversification, penny stocks could add a lot of value to your portfolios. Penny…

The mania surrounding penny stocks — related to the “meme stocks” and Reddit stocks trend — is taking a breather right now. But does that mean this is an area to stay away from when it comes to opportunities? Yes and no. On one hand, the trend that sent many stocks “to the moon” may…

More than a year ago, a colleague of mind introduced me to Mind Medicine (NASDAQ:MNMD). Back then, MNMD stock was trading in the over-the-counter market, which was the first red flag – or at least a yellow one. With their typically low volume and ridiculous bid-ask spreads, OTC-based securities are not something you should dabble…

Mind Medicine (NASDAQ:MNMD) is a clinical-stage biotech company that is developing multiple psychedelic treatments for various mental health conditions. With numerous therapy programs in development, the goal is to effectively leverage the latest innovations to develop medicines that have never been commercialized previously. However, with no revenues, mounting losses, and an array of business risks,…

Two factors immediately make Mind Medicine (NASDAQ:MNMD) stock difficult to analyze objectively. Source: Shutterstock First, MNMD stock enjoyed a massively strong session on June 7 soaring just a hair under 22%. Second and more importantly on a personal level, I own shares of Mind Medicine. When I checked my account today, MNMD contributed very handsomely…

Psychedelic therapy developer Mind Medicine (NASDAQ:MNMD) stock has been on fire this year, generating more than 100% in returns in the past six months. Source: local_doctor / Shutterstock.com It currently has the most diversified pipeline of psychedelics in clinical development and R&D, tackling mental health. There has been a steep rise in mental health ailments…